Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael G Collins

Showing results (41-50 of 44) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 44 results.
Trials|May 27, 2020
Study Protocol for Better Evidence for Selecting Transplant Fluids (BEST-Fluids): a pragmatic, registry-based, multi-center, double-blind, randomized controlled trial evaluating the effect of intravenous fluid therapy with Plasma-Lyte 148 versus 0.9% saline on delayed graft function in deceased donor kidney transplantationMichael G Collins, Magid A Fahim, Elaine M Pascoe, et al.
Nature Nanotechnology|August 23, 2024
Acid-degradable lipid nanoparticles enhance the delivery of mRNASheng Zhao, Kewa Gao, Hesong Han, et al.
Lancet (London, England)|June 21, 2023
Balanced crystalloid solution versus saline in deceased donor kidney transplantation (BEST-Fluids): a pragmatic, double-blind, randomised, controlled trialMichael G Collins, Magid A Fahim, Elaine M Pascoe, et al.
Transplantation Direct|December 8, 2022
Baseline Characteristics and Representativeness of Participants in the BEST-Fluids Trial: A Randomized Trial of Balanced Crystalloid Solution Versus Saline in Deceased Donor Kidney TransplantationMichael G Collins, Magid A Fahim, Elaine M Pascoe, et al.
Pageof 5

Showing results (41-50 of 44) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 44 results.
Trials|May 27, 2020
Study Protocol for Better Evidence for Selecting Transplant Fluids (BEST-Fluids): a pragmatic, registry-based, multi-center, double-blind, randomized controlled trial evaluating the effect of intravenous fluid therapy with Plasma-Lyte 148 versus 0.9% saline on delayed graft function in deceased donor kidney transplantationMichael G Collins, Magid A Fahim, Elaine M Pascoe, et al.
Nature Nanotechnology|August 23, 2024
Acid-degradable lipid nanoparticles enhance the delivery of mRNASheng Zhao, Kewa Gao, Hesong Han, et al.
Lancet (London, England)|June 21, 2023
Balanced crystalloid solution versus saline in deceased donor kidney transplantation (BEST-Fluids): a pragmatic, double-blind, randomised, controlled trialMichael G Collins, Magid A Fahim, Elaine M Pascoe, et al.
Transplantation Direct|December 8, 2022
Baseline Characteristics and Representativeness of Participants in the BEST-Fluids Trial: A Randomized Trial of Balanced Crystalloid Solution Versus Saline in Deceased Donor Kidney TransplantationMichael G Collins, Magid A Fahim, Elaine M Pascoe, et al.
Pageof 5